{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T23:19:56Z","timestamp":1788477596333,"version":"build-2803163510"},"reference-count":52,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T00:00:00Z","timestamp":1777334400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003593","name":"National Council for Scientific and Technological Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Global Health"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.langlo.2026.103979","type":"journal-article","created":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T19:36:52Z","timestamp":1783712212000},"page":"103979","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Genetic testing versus clinical screening for relatives of patients with hypertrophic cardiomyopathy in the Brazilian public health system: a cost-utility analysis"],"prefix":"10.1016","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3848-6216","authenticated-orcid":false,"given":"Andressa","family":"Braga","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marisa","family":"Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernardo","family":"Tura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcelo","family":"Correia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana Bastos","family":"Carvalho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tais Hanae","family":"Kasai-Brunswick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raiana Andrade Quintanilha","family":"Barbosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dilza","family":"Campos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milene","family":"Rangel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Magliano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.langlo.2026.103979_bib1","doi-asserted-by":"crossref","DOI":"10.36660\/abc.20240415","article-title":"Diretriz sobre diagn\u00f3stico e tratamento da cardiomiopatia hipertr\u00f3fica \u2013 2024","volume":"121","author":"Fernandes","year":"2024","journal-title":"Arq Bras Cardiol"},{"key":"10.1016\/j.langlo.2026.103979_bib2","doi-asserted-by":"crossref","first-page":"e159","DOI":"10.1016\/j.jacc.2020.08.045","article-title":"2020 AHA\/ACC guideline for the diagnosis and treatment of patients with hypertrophic cardiomyopathy: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"76","author":"Ommen","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.langlo.2026.103979_bib3","doi-asserted-by":"crossref","first-page":"3503","DOI":"10.1093\/eurheartj\/ehad194","article-title":"2023 ESC Guidelines for the management of cardiomyopathies","volume":"44","author":"Arbelo","year":"2023","journal-title":"Eur Heart J"},{"key":"10.1016\/j.langlo.2026.103979_bib5","first-page":"1503","article-title":"Canadian Cardiovascular Society clinical practice update on contemporary management of the patient with hypertrophic cardiomyopathy","volume":"40","author":"Crean","year":"2024","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.langlo.2026.103979_bib7","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s12265-017-9730-8","article-title":"Usefulness of genetic testing in hypertrophic cardiomyopathy: an analysis using real-world data","volume":"10","author":"Alejandra Restrepo-Cordoba","year":"2017","journal-title":"J Cardiovasc Transl Res"},{"key":"10.1016\/j.langlo.2026.103979_bib8","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.1093\/eurheartj\/ehae421","article-title":"Genetics of hypertrophic cardiomyopathy: established and emerging implications for clinical practice","volume":"45","author":"Lopes","year":"2024","journal-title":"Eur Heart J"},{"key":"10.1016\/j.langlo.2026.103979_bib9","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1136\/heartjnl-2011-300368","article-title":"A cost-effectiveness model of genetic testing for the evaluation of families with hypertrophic cardiomyopathy","volume":"98","author":"Ingles","year":"2012","journal-title":"Heart"},{"key":"10.1016\/j.langlo.2026.103979_bib10","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1093\/eurheartj\/ehq067","article-title":"DNA testing for hypertrophic cardiomyopathy: a cost-effectiveness model","volume":"31","author":"Wordsworth","year":"2010","journal-title":"Eur Heart J"},{"key":"10.1016\/j.langlo.2026.103979_bib11","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.gim.2021.10.008","article-title":"A systematic review of the methodological quality of economic evaluations in genetic screening and testing for monogenic disorders","volume":"24","author":"Johnson","year":"2022","journal-title":"Genet Med"},{"key":"10.1016\/j.langlo.2026.103979_bib12","doi-asserted-by":"crossref","first-page":"346","DOI":"10.3390\/children8050346","article-title":"Incorporating cascade effects of genetic testing in economic evaluation: a scoping review of methodological challenges","volume":"8","author":"Cernat","year":"2021","journal-title":"Children"},{"key":"10.1016\/j.langlo.2026.103979_bib13","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.3390\/ijerph21111498","article-title":"Mortality from hypertrophic cardiomyopathy in Brazil\u2014historical series","volume":"21","author":"Santos","year":"2024","journal-title":"Int J Environ Res Public Health"},{"key":"10.1016\/j.langlo.2026.103979_bib14","doi-asserted-by":"crossref","DOI":"10.36660\/abchf.20230011","article-title":"National Network of Cardiovascular Genomics: implementing genetic diagnosis in cardiology in the Brazilian Unified Health System","volume":"3","author":"Kasai-Brunswick","year":"2023","journal-title":"ABC Heart Fail Cardiomyop"},{"key":"10.1016\/j.langlo.2026.103979_bib15","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1002\/ajhb.22714","article-title":"Meta-analysis of Brazilian genetic admixture and comparison with other Latin America countries","volume":"27","author":"Moura","year":"2015","journal-title":"Am J Hum Biol"},{"key":"10.1016\/j.langlo.2026.103979_bib17","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.jval.2013.02.002","article-title":"Consolidated Health Economic Evaluation Reporting Standards (CHEERS)\u2014explanation and elaboration: a report of the ISPOR Health Economic Evaluation Publication Guidelines Good Reporting Practices Task Force","volume":"16","author":"Husereau","year":"2013","journal-title":"Value Health"},{"key":"10.1016\/j.langlo.2026.103979_bib20","author":"Ward"},{"key":"10.1016\/j.langlo.2026.103979_bib21","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.jacc.2020.06.011","article-title":"Penetrance of hypertrophic cardiomyopathy in sarcomere protein mutation carriers","volume":"76","author":"Lorenzini","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.langlo.2026.103979_bib22","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCGEN.117.001896","article-title":"Outcomes of contemporary family screening in hypertrophic cardiomyopathy","volume":"11","author":"van Velzen","year":"2018","journal-title":"Circ Genom Precis Med"},{"key":"10.1016\/j.langlo.2026.103979_bib24","doi-asserted-by":"crossref","DOI":"10.1136\/openhrt-2021-001815","article-title":"Diagnostic validity and clinical utility of genetic testing for hypertrophic cardiomyopathy: a systematic review and meta-analysis","volume":"9","author":"Christian","year":"2022","journal-title":"Open Heart"},{"key":"10.1016\/j.langlo.2026.103979_bib26","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1001\/jamacardio.2019.4534","article-title":"and the Hypertrophic Cardiomyopathy Outcomes investigators. Mortality among referral patients with hypertrophic cardiomyopathy vs the general European population","volume":"5","author":"Lorenzini","year":"2020","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.langlo.2026.103979_bib27","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.ijcard.2011.08.083","article-title":"Health status of cardiac genetic disease patients and their at-risk relatives","volume":"165","author":"Ingles","year":"2013","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.langlo.2026.103979_bib28","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.vhri.2018.10.009","article-title":"A comparison of UK and Brazilian SF-6D preference weights when applied to a Brazilian urban population","volume":"20","author":"Ferraz","year":"2019","journal-title":"Value Health Reg Issues"},{"key":"10.1016\/j.langlo.2026.103979_bib30","author":"Rohatgi"},{"key":"10.1016\/j.langlo.2026.103979_bib34","series-title":"Contas do SUS na perspectiva da contabilidade internacional: Brasil, 2010\u20132014","year":"2018"},{"key":"10.1016\/j.langlo.2026.103979_bib35","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.ijcard.2020.07.036","article-title":"Prevalence, causes and predictors of cardiovascular hospitalization in patients with hypertrophic cardiomyopathy","volume":"318","author":"Ciabatti","year":"2020","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.langlo.2026.103979_bib38","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1161\/CIRCULATIONAHA.117.033200","article-title":"Genotype and lifetime burden of disease in hypertrophic cardiomyopathy: insights from the Sarcomeric Human Cardiomyopathy Registry (SHaRe)","volume":"138","author":"Ho","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.langlo.2026.103979_bib39","doi-asserted-by":"crossref","first-page":"3672","DOI":"10.1093\/eurheartj\/ehz396","article-title":"Family screening for hypertrophic cardiomyopathy: is it time to change practice guidelines?","volume":"40","author":"Lafreniere-Roula","year":"2019","journal-title":"Eur Heart J"},{"key":"10.1016\/j.langlo.2026.103979_bib40","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCGEN.120.003189","article-title":"Impact of genetic testing for cardiomyopathy on emotional well-being and family dynamics: a study of parents and adolescents","volume":"14","author":"Ahimaz","year":"2021","journal-title":"Circ Genom Precis Med"},{"key":"10.1016\/j.langlo.2026.103979_bib41","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1002\/jgc4.1604","article-title":"The uptake and utility of genetic testing and genetic counseling for hypertrophic cardiomyopathy\u2014a systematic review and meta-analysis","volume":"31","author":"Cirino","year":"2022","journal-title":"J Genet Couns"},{"key":"10.1016\/j.langlo.2026.103979_bib42","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1002\/humu.23220","article-title":"Exomic variants of an elderly cohort of Brazilians in the ABraOM database","volume":"38","author":"Naslavsky","year":"2017","journal-title":"Hum Mutat"},{"key":"10.1016\/j.langlo.2026.103979_bib43","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.tcm.2014.05.009","article-title":"The value of cardiac genetic testing","volume":"24","author":"Ingles","year":"2014","journal-title":"Trends Cardiovasc Med"},{"key":"10.1016\/j.langlo.2026.103979_bib44","article-title":"Micro-costing diagnostic genomic sequencing: a systematic review","volume":"25","author":"Gonzalez","year":"2023","journal-title":"Genet Med"},{"key":"10.1016\/j.langlo.2026.103979_bib45","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1038\/gim.2014.205","article-title":"Results of clinical genetic testing of 2,912 probands with hypertrophic cardiomyopathy: expanded panels offer limited additional sensitivity","volume":"17","author":"Alfares","year":"2015","journal-title":"Genet Med"},{"key":"10.1016\/j.langlo.2026.103979_bib46","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1111\/j.1524-4733.2008.00489.x","article-title":"Transferability of economic evaluations across jurisdictions: ISPOR Good Research Practices Task Force report","volume":"12","author":"Drummond","year":"2009","journal-title":"Value Health"},{"key":"10.1016\/j.langlo.2026.103979_bib47","article-title":"Hypertrophic cardiomyopathy diagnosis and treatment in high- and low-income countries: a narrative review","volume":"15","author":"Calderon Martinez","year":"2023","journal-title":"Cureus"},{"key":"10.1016\/j.langlo.2026.103979_bib48","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1093\/eurheartj\/ehx819","article-title":"The Cardiomyopathy Registry of the EURObservational Research Programme of the European Society of Cardiology: baseline data and contemporary management of adult patients with cardiomyopathies","volume":"39","author":"Charron","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.langlo.2026.103979_bib49","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCGENETICS.116.001620","article-title":"Nonfamilial hypertrophic cardiomyopathy: prevalence, natural history, and clinical implications","volume":"10","author":"Ingles","year":"2017","journal-title":"Circ Cardiovasc Genet"},{"key":"10.1016\/j.langlo.2026.103979_bib50","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/s41431-022-01259-8","article-title":"The implementation of large-scale genomic screening or diagnostic programmes: a rapid evidence review","volume":"31","author":"Alarc\u00f3n Garavito","year":"2023","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.langlo.2026.103979_bib51","doi-asserted-by":"crossref","first-page":"549","DOI":"10.2217\/pme-2021-0153","article-title":"Medical geneticists, genetic diseases and services in Brazil in the age of personalized medicine","volume":"19","author":"Bonilla","year":"2022","journal-title":"Per Med"},{"key":"10.1016\/j.langlo.2026.103979_bib52","doi-asserted-by":"crossref","first-page":"973","DOI":"10.3390\/genes15080973","article-title":"Medical genetics in Brazil in the 21st century: a thriving specialty and its incorporation in public health policies","volume":"15","author":"Horovitz","year":"2024","journal-title":"Genes (Basel)"},{"key":"10.1016\/j.langlo.2026.103979_bib53","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.ijcard.2015.03.070","article-title":"Social determinants of health in the setting of hypertrophic cardiomyopathy","volume":"184","author":"Ingles","year":"2015","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.langlo.2026.103979_bib54","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2022.831918","article-title":"Social inequalities in non-ischemic cardiomyopathies","volume":"9","author":"Amiya","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.langlo.2026.103979_bib55","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/3750879","article-title":"Disparities in the diagnosis of hypertrophic obstructive cardiomyopathy: a narrative review of current literature","volume":"2018","author":"Burns","year":"2018","journal-title":"Cardiol Res Pract"},{"key":"10.1016\/j.langlo.2026.103979_bib56","doi-asserted-by":"crossref","first-page":"2573","DOI":"10.1016\/j.jacc.2021.10.020","article-title":"Associations of race and ethnicity with presentation and outcomes of hypertrophic cardiomyopathy: JACC Focus Seminar 6\/9","volume":"78","author":"Ntusi","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.langlo.2026.103979_bib57","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1161\/01.CIR.92.4.785","article-title":"Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA Study. Coronary Artery Risk Development in (Young) Adults","volume":"92","author":"Maron","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/j.langlo.2026.103979_bib58","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1001\/jamacardio.2019.4638","article-title":"Association of race with disease expression and clinical outcomes among patients with hypertrophic cardiomyopathy","volume":"5","author":"Eberly","year":"2020","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.langlo.2026.103979_bib59","doi-asserted-by":"crossref","DOI":"10.1161\/HCG.0000000000000067","article-title":"Genetic testing for inherited cardiovascular diseases: a scientific statement from the American Heart Association","volume":"13","author":"Musunuru","year":"2020","journal-title":"Circ Genom Precis Med"},{"key":"10.1016\/j.langlo.2026.103979_bib61","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0216620","article-title":"Potential determinants of health system efficiency: evidence from Latin America and the Caribbean","volume":"14","author":"Moreno-Serra","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.langlo.2026.103979_bib62","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s12913-021-07376-2","article-title":"Brazilian private health system: history, scenarios, and trends","volume":"22","author":"Cruz","year":"2022","journal-title":"BMC Health Serv Res"},{"key":"10.1016\/j.langlo.2026.103979_bib63","doi-asserted-by":"crossref","DOI":"10.1590\/0102-311xpt262221","article-title":"Crise econ\u00f4mica e disparidades no gasto, oferta e utiliza\u00e7\u00e3o de servi\u00e7os p\u00fablicos e privados de sa\u00fade no Brasil no per\u00edodo entre 2011 e 2019","volume":"38","author":"Costa","year":"2022","journal-title":"Cad Saude Publica"},{"key":"10.1016\/j.langlo.2026.103979_bib64","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1080\/13696998.2023.2195753","article-title":"A systematic review of SF-6D health state valuation studies","volume":"26","author":"Wang","year":"2023","journal-title":"J Med Econ"},{"key":"10.1016\/j.langlo.2026.103979_bib65","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.ajhg.2023.01.018","article-title":"Australian Genomics: outcomes of a 5-year national program to accelerate the integration of genomics in healthcare","volume":"110","author":"Stark","year":"2023","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.langlo.2026.103979_bib66","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1038\/s41436-020-01030-8","article-title":"Evaluating the resource implications of different service delivery models for offering additional genomic findings","volume":"23","author":"Vu","year":"2021","journal-title":"Genet Med"}],"container-title":["The Lancet Global Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214109X26001415?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214109X26001415?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T23:05:34Z","timestamp":1788476734000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2214109X26001415"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":52,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S2214109X26001415"],"URL":"https:\/\/doi.org\/10.1016\/j.langlo.2026.103979","relation":{},"ISSN":["2214-109X"],"issn-type":[{"value":"2214-109X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Genetic testing versus clinical screening for relatives of patients with hypertrophic cardiomyopathy in the Brazilian public health system: a cost-utility analysis","name":"articletitle","label":"Article Title"},{"value":"The Lancet Global Health","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.langlo.2026.103979","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"103979"}}